Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to $425025.3.

  • AC Immune's Depreciation & Amortization (CF) rose 257.38% to $425025.3 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 419.36%. This contributed to the annual value of $1.7 million for FY2024, which is 1006.81% down from last year.
  • Per AC Immune's latest filing, its Depreciation & Amortization (CF) stood at $425025.3 for Q3 2025, which was up 257.38% from $438464.2 recorded in Q2 2025.
  • AC Immune's Depreciation & Amortization (CF)'s 5-year high stood at $539118.9 during Q3 2021, with a 5-year trough of $401522.4 in Q1 2025.
  • Over the past 5 years, AC Immune's median Depreciation & Amortization (CF) value was $453530.0 (recorded in 2022), while the average stood at $461531.1.
  • In the last 5 years, AC Immune's Depreciation & Amortization (CF) soared by 3713.89% in 2021 and then crashed by 1587.57% in 2022.
  • Over the past 5 years, AC Immune's Depreciation & Amortization (CF) (Quarter) stood at $527068.0 in 2021, then decreased by 9.01% to $479566.0 in 2022, then fell by 1.97% to $470106.8 in 2023, then dropped by 12.83% to $409806.4 in 2024, then increased by 3.71% to $425025.3 in 2025.
  • Its Depreciation & Amortization (CF) stands at $425025.3 for Q3 2025, versus $438464.2 for Q2 2025 and $401522.4 for Q1 2025.